Ares Capital (NASDAQ:ARCC - Get Free Report) had its price objective upped by analysts at Keefe, Bruyette & Woods from $22.00 to $23.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has an "outperform" rating on the investment management company's stock. Keefe, Bruyette & Woods' price target indicates a potential upside of 2.80% from the company's previous close.
A number of other brokerages have also recently issued reports on ARCC. B. Riley upgraded Ares Capital from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $22.50 to $23.50 in a report on Wednesday. Royal Bank Of Canada decreased their target price on shares of Ares Capital from $24.00 to $23.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. JPMorgan Chase & Co. lowered their price target on Ares Capital from $24.50 to $22.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. UBS Group upped their price objective on shares of Ares Capital from $22.00 to $22.50 and gave the stock a "neutral" rating in a research report on Wednesday, July 16th. Finally, Wells Fargo & Company lifted their price target on Ares Capital from $21.00 to $22.00 and gave the company an "overweight" rating in a research note on Friday, June 27th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat, Ares Capital presently has a consensus rating of "Moderate Buy" and an average target price of $22.86.
Check Out Our Latest Stock Analysis on Ares Capital
Ares Capital Stock Down 1.1%
NASDAQ ARCC traded down $0.26 during trading hours on Wednesday, hitting $22.37. 769,048 shares of the company traded hands, compared to its average volume of 4,592,192. The stock has a market capitalization of $15.53 billion, a price-to-earnings ratio of 10.92 and a beta of 0.67. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.40 and a current ratio of 1.14. Ares Capital has a twelve month low of $18.26 and a twelve month high of $23.84. The business's 50-day moving average is $22.24 and its 200-day moving average is $22.05.
Ares Capital (NASDAQ:ARCC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The investment management company reported $0.50 EPS for the quarter, missing analysts' consensus estimates of $0.51 by ($0.01). The business had revenue of $614.00 million for the quarter, compared to the consensus estimate of $748.76 million. Ares Capital had a return on equity of 10.48% and a net margin of 44.94%. During the same quarter in the previous year, the business posted $0.61 EPS. Sell-side analysts anticipate that Ares Capital will post 2.19 earnings per share for the current year.
Institutional Trading of Ares Capital
Several hedge funds have recently modified their holdings of ARCC. Elequin Capital LP bought a new position in shares of Ares Capital in the 1st quarter worth $30,000. Montag & Caldwell LLC bought a new stake in Ares Capital during the fourth quarter worth $33,000. Continuum Advisory LLC boosted its holdings in shares of Ares Capital by 320.7% in the 1st quarter. Continuum Advisory LLC now owns 1,628 shares of the investment management company's stock worth $36,000 after buying an additional 1,241 shares during the last quarter. CNB Bank purchased a new position in Ares Capital in the second quarter valued at about $36,000. Finally, Harbor Asset Planning Inc. purchased a new position in Ares Capital in the second quarter valued at approximately $38,000. Institutional investors own 27.38% of the company's stock.
Ares Capital Company Profile
(
Get Free Report)
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.
Recommended Stories

Before you consider Ares Capital, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ares Capital wasn't on the list.
While Ares Capital currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.